Your browser doesn't support javascript.
loading
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.
Kawano, Yawara; Hata, Hiroyuki; Takashio, Seiji; Tsujita, Kenichi; Ueda, Mitsuharu; Matsuoka, Masao.
Afiliação
  • Kawano Y; Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Hata H; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
  • Takashio S; Division of Informative Clinical Sciences, Faculty of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Tsujita K; Amyloidosis Center, Kumamoto University Hospital, Kumamoto, Japan.
  • Ueda M; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Matsuoka M; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Br J Haematol ; 198(3): e38-e41, 2022 08.
Article em En | MEDLINE | ID: mdl-35524546
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article